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ABSTRACT
The amino acid sequence of Dnmt2 is very similar to the catalytic domains of bacterial and eukaryotic
DNA-(cytosine 5)-methyltransferases, but it efﬁciently catalyzes tRNA methylation, while its DNA
methyltransferase activity is the subject of controversial reports with rates varying between zero and very
weak. By using composite nucleic acid molecules as substrates, we surprisingly found that DNA fragments,
when presented as covalent DNA-RNA hybrids in the structural context of a tRNA, can be more efﬁciently
methylated than the corresponding natural tRNA substrate. Furthermore, by stepwise development of
tRNAAsp, we showed that this natural Dnmt2 substrate could be engineered to employ RNAs that act like
guide RNAs in vitro. The 5’-half of tRNAAsp was able to efﬁciently guide methylation toward a single
stranded tRNA fragment as would result from tRNA cleavage by tRNA speciﬁc nucleases. In a more
artiﬁcial setting, a composite system of guide RNAs could ultimately be engineered to enable the enzyme
to perform cytidine methylation on single stranded DNA in vitro.
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Introduction
A central question that may join the ﬁelds of DNA and
RNA modiﬁcation concerns the action of such rare enzymes
that act on nucleobases in both types of nucleic acid.1,2 Ever
since the discovery of its robust tRNA methylation,3 Dnmt2
has been a paradigm in this respect, because its nearest
neighbors in evolution all are DNA-cytosine C5-methyl-
transferases (MTases) and methylate DNA.4 While the
deoxyribo-5-methylcytidine (5mC or dm5C) residues
formed by these related Dnmt enzymes are classical epige-
netic marks, the role of Dnmt2 and its product, ribo-5-
methylcytidine (rm5C) at position 38 of different tRNAs, is
ill understood at present, with different studies showing
effects of this modiﬁcation on tRNA fragmentation and sta-
bility,5,6 tRNA charging7 and ﬁdelity in translation.8 The
search for a Dnmt2 substrate had been exclusively focused
on DNA until the discovery of tRNA methylation activity
of Dnmt2 in the seminal paper by Goll.3 With the discovery
of tRNAAsp as very active substrate the search for substrates
took an unexpected turn, and reports on DNA methylation
were now subject to highly controversial discussion.3,9-13
Meanwhile, a recurrent set of tRNAs other than tRNAAsp
have been identiﬁed as Dnmt2 substrates in various organ-
isms. These include tRNAVal and tRNAGly in mouse,6
tRNAGlu in Schizosaccharomyces pombe,14 tRNAGly and
tRNAGlu in Dictyostelium discoideum,15 tRNAVal, and
tRNAGly in Drosophila melanogaster 5,16 and tRNAGly in
Arabidopsis thaliana.17 In Geobacter sulfurreducens, which
so far represents the only prokaryote known to express a
Dnmt2 protein, substrate speciﬁcity includes tRNAGlu but
not tRNAAsp, and the discrimination hinges upon the pres-
ence of certain sequence elements in the variable loop.18
Since the revelation of Dnmt2 as an RNA methyltransfer-
ease, the performance of methods for selective and sensitive
detection of nucleic acid methylation has signiﬁcantly
improved.19 One particularly important development was that
bisulﬁte mapping of dm5C in DNA, an established method that
has seen dozens of improvements over the decades, was ﬁnally
adapted to rm5C detection in RNA.16 This approach 17,20-24 and
a related transcriptome-wide approach based on azacytidine 25
have produced numerous candidates for rm5C in RNA,
although most of these candidates were not attributed to
Dnmt2 activity, but rather dependent on Trm4/NSUN2, a
related bona ﬁde RNA methyltransferases.6 Although these
approaches allegedly identiﬁed several RNAs as Dnmt2 sub-
strates, to date there is no published biochemical data showing
any in vitro activity of Dnmt2 on substrates other than tRNA.4
This leaves open the possibility that additional factors inﬂuence
or even determine substrate speciﬁcity of Dnmt2 in vivo or that
search paradigms have not been correctly aimed.
Inspired by the ongoing discussion about whether Dnmt2 is
capable of methylating DNA, or any other RNA in addition to
tRNA, we have set out to determine if the biochemical potential
for DNA methylation in vitro is present in the enzyme. We
argued that composite nucleic acid molecules with varying con-
tents of RNA versus DNA should allow gauging a preference of
an enzyme for one or the other type of nucleic acid. We surpris-
ingly found that Dnmt2 can efﬁciently methylate short DNA
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stretches when these are presented in the form of covalent chi-
meric molecules in the structural context of a tRNA. This activ-
ity is interpreted as a residual property originating from the
evolutionary proximity of Dnmt2 to DNA methyltransfer-
ases.4,26 Furthermore, starting from these structures, artiﬁcial
guide RNAs can be developed, which allow targeting of Dnmt2
activity to the methylation of short single stranded RNA or
DNA oligomers in vitro.
Results and discussion
Dnmt2, but not Trm4, methylates single deoxycytidines at
the deﬁned target site
Since linear double-strand DNA is a poor in vitro Dnmt2 sub-
strate at best,9 whereas tRNAAsp is efﬁciently methylated, we
have constructed a series of tRNAAsp hybrids, in which RNA
nucleotides were substituted with their corresponding deoxy-
surrogates, starting with the single target nucleotide C38, which
is methylated to rm5C in native tRNAAsp.3 Several hybrid con-
structs of increasing DNA content were assembled from syn-
thetic fragments by splint ligation 27 and their properties as
methylation substrates of recombinant human Dnmt2 28 were
assessed in a tritium incorporation assay with 3H-SAM.29 As
expected, the natural all-ribo tRNAAsp displayed robust
methylation (Fig. 1).
However, we surprisingly found that a chimeric tRNA
with a single deoxyribose substitution at the target site C38
(tRNAAspdC38) was an even better substrate for hDnmt2
(Fig. 1a, b, Fig. S1). As a negative control, a dm5C38 hybrid
containing synthetic dm5C at position 38 did not show any
methyl group acceptor properties in the tritium incorpo-
ration assay (Fig. 1b, blue trace). To conﬁrm the structure
of the methylated nucleotide, both methylated substrates
were re-isolated from the reaction mixture, hydrolyzed to
nucleosides, and analyzed by LC-MS/MS. Using fragmenta-
tion patterns from synthetic rm5C and dm5C (Fig. 2a), we
established a multiple reaction monitoring (MRM) fragmen-
tation method with a limit of detection in the single digit
femtomol range.30 While no methylated deoxycytidine was
present in the substrates before the reaction, analysis of the
material after the reaction revealed the presence of a new
peak in the hybrid tRNAAspdC38 that corresponds to dm5C
in both retention time and fragmentation pattern (Fig. 2b).
Both RNAs contained trace amounts of rm5C, that was
already present in the synthetic oligonucleotides used for
ligation of the full length substrates,30 but a strong increase
of rm5C in the all-ribo substrate was detected upon incuba-
tion with Dnmt2. These results clearly show methylation of
dC38, and prove that Dnmt2 can accept and modify deoxy-
nucleotides in its active site. To analyze, whether this is a
particular feature of Dnmt2, or a generic features of m5C:
MTases, we performed analogous experiments with yeast
Trm4, an enzyme known to methylate cytidines in the vari-
able loop of yeast tRNAs.31 While recombinant Trm4
showed robust tritium incorporation into an all-ribo tRNA
(Fig. S2), substitution of the known target sites rC48 and
rC49 with dC led to complete ablation of tritium incorpo-
ration, suggesting strongly that Trm4, in contrast to
Dnmt2, is not capable of DNA methylation.
Dnmt2 methylates deoxycytidines faster than
ribocytidines at its target site
An in-depth analysis of the methylation reaction showed that it
followed Michaelis Menten kinetics (Fig. S3), yielding similar
apparent Km values for all-ribo tRNA
Asp and hybrid
tRNAAspdC38 (4.2 mM vs. 4.0 mM), while the kcat value of the
hybrid tRNAAspdC38 was increased by a factor of 2.3. This
indicates similar binding properties combined with an acceler-
ated turnover as a consequence of the lack of the 2’-hydrox-
ylgroup at position 38. In the absence of a crystal structure of
Dnmt2 29 complexed to its tRNA substrate, it is unclear if the
2’-hydroxylgroup is interacting directly with the enzyme,32 as
an inﬂuence on base-ﬂipping is possible as well.33
Yet more surprising observations were made in comparing
hybrid tRNA with further increasing DNA content:
Figure 1. Tritium incorporation assay suggests that Dnmt2 methylates a tRNA containing a deoxycytidine at position 38. (A) Cloverleaf structure of unmodiﬁed human
cytosolic tRNAAsp. Position 38 has been engineered to contain rC, dC, or dm5C in three hybrid tRNAs of corresponding name. (B) In vitro methylation measured by tritium
incorporation from 3H-SAM. Standard deviations of three replicates are given in Fig. S1.
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introduction of a 3 nucleotide DNA stretch spanning from d37
to d39 did also improve methylation in comparison to all-ribo
tRNAAsp (Upper curves in Fig. 3).
Dnmt2 methylates DNA presented as covalent hybrid with
RNA in the structural context of a tRNA
In chimeras with longer deoxynucleotide stretches, substrate
quality decreased with the DNA content, but a hybrid
tRNAAspd36-40, containing a stretch of 5 deoxynucleotides
between positions 36 and 40, was still a substrate comparable
to the all-ribo tRNAAsp. Chimeric tRNAAspd34-43 (10 deoxy-
nucleotides) was the ﬁrst to show clearly decreased, albeit still
readily detectable activity (Fig. 3).
Exploring the limits of DNA substitution in tRNAAsp
The above data clearly show methylation of DNA, provided it is
presented in a structure that can be assumed to resemble the
canonical tRNA substrate structure to a reasonable degree. The
data also implies a drop in methylation efﬁciency with increas-
ing DNA content. These ﬁndings provoke numerous questions
as to where and how much DNA could be incorporated into
the tRNA substrate, and if, ultimately, this approach would
reveal an all-DNA substrate.
In the investigation of further DNA-tRNA chimeras of
increasing DNA content, the substrate quality was assessed
in an endpoint assay after 120 minutes, foregoing a time-
consuming determination of Michaelis-Menten parameters.
Results, as given in Table 1a, were normalized to the all-
ribo tRNA as a reference. Based on this quantitative data,
a qualitative ranking in descending order of substrate
quality was visualized in Fig. 4 to facilitate the following
discussion. When the DNA stretch starting at position 34,
was further extended toward, and into, the 5’-side of the
T-stem, methylation efﬁciency remained at a moderate
level of »25-40% of the all-ribo tRNA (Fig. 4e,f,g). To
assess the general requirement for the 3D structure of a
tRNA, an anticodon stem loop construct (ASL) of tRNAAsp
was tested, but found to not be a substrate. Because this
strongly suggested that typical elements of tRNA architec-
ture were required for substrate recognition and methyla-
tion by Dnmt2, the possibility of extending the DNA
stretch into the D- and T-stems was tested by chimeras
featuring either an all-deoxy-T-domain or an all-deoxy-D-
domain. However, the fact that replacement of either the
Figure 2. LC-MS analysis conﬁrms that Dnmt2 methylates a tRNA containing a deoxycytidine at position 38. (A) Fragmentation patterns and mass transitions
used for scanning of rm5C and dm5C in LC-MS. (B) LC-MS analysis of all-ribo tRNAAsp and hybrid tRNAAspdC38 before and after in vitro methylation by human
Dnmt2.
Figure 3. Dnmt2 methylates hybrid tRNAs containing up to 10 deoxynucleotides. (A) Positions of DNA substitutions in the tRNA cloverleaf in hybrid tRNAs. (B) Methyla-
tion of hybrid tRNAs of increasing DNA content. Average values and standard deviations are given in Fig. S1.
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entire D-loop or the entire T-loop led to undetectable lev-
els of methylation, ablated the idea that an all-DNA sub-
strate might be derived from the tRNA structure in its full
length.
In vitro development of an RNA-guided system for DNA
methylation (RgD)
Having delineated the limits of the DNA content in a covalent
DNA-RNA chimera, we turned to the task, of developing a
non-covalent RNA-DNA hybrid that might support DNA
methyltransferase activity to Dnmt2. Using the previous chi-
mera as a starting point, we tested the effects on methylation of
several manipulations, designed to lead to guide-RNAs for
Dnmt2 methylation of a ssDNA fragment. These manipula-
tions are graphically summarized in the inset in Fig. 5, and
comprise (i) the introduction of a nick in the anticodon at a
previous junction of RNA and DNA domains, e.g. at position
34 of constructs 4e-4g (constructs 5e, 5i). Furthermore, (ii) the
DNA content would be enlarged similarly to what was dis-
cussed above, including also an oligo-dC tail adjacent to the
target C38 site to offer multiple potential methylation sites (5a,
5c, 5f-h, 5j). The generated bipartite system would then (iii) be
stabilized by extending basepairs in the newly opened antico-
don (construct 5g), and (iv) near the 3’-CCA end of the tRNA
(construct 5h). The results in Table 1b and the activity scale in
Fig. 5 show, that a nick between positions 33 and 34 as in sub-
strates 5i and 5e, which results in an open anticodon loop, is
still tolerated by the enzyme, although substrate activity of con-
struct 5i is clearly reduced in comparison to the intact all-ribo
tRNA (4c,5b). This result, although obtained rather in passing,
is of biological signiﬁcance. It shows that a hybrid of 2 tRNA-
fragments (tRFs), which is essentially a nicked tRNA as would
result from speciﬁc cleavage by a tRNase such as angiogenin,5
was still methylated. Therefore, the 5’-tRF half could be viewed
as a “guide RNA” that steers the enzyme to an RNA target, in
this case the 3’-tRF. We took the biochemical proof of concept of
a tRF as guide RNA for methylation as an important prerequisite
to engineer an artiﬁcial system for ssDNA methylation. To this
Table 1. tRNA-derivatives constructed by ligation and/or hybridization. Numbering
in column 2 corresponds to that used in Figs. 4 and 5.
Name
tRNA
derivative
Relative
efﬁciency / %
N = SD / %
(a) See Fig. 4 for graphical representation
all-ribo tRNAAsp 4c, 5b 100
tRNAAspdC38 4a 177 3 74
tRNAAspd37-39 4b 180 3 56
tRNAAspd36-40 4d 103 3 12
tRNAAspd34-51 4e 38 3 4
tRNAAspd34-46 4f 32 3 3
tRNAAspd34-43 4g 25 3 6
(b) See Fig. 5 for graphical representation
nicked tRNAAsp dCdC38 5a 145 3 20
nicked tRNAAspdCdC38-43 5c 72 3 7
nicked tRNAAsp d27-33 5d 71 3 3
nicked tRNAAspdC38 5e 43 3 5
nicked tRNAAspI 5f 43 3 3
nicked tRNAAspdX-43-3’HX 5g 22 3 3
nicked tRNAAspdX-53-5’HX 5h 13 3 1
nicked all-ribo tRNAAsp 5i 11 3 0
nicked tRNAAspdX-53 5j 9 3 1
See Fig. 6
RgD 6A 2 3 0,2
Figure 4. Relative methylation efﬁciency of covalent chimeric tRNAsAsp compared
to the all-ribo tRNAAsp (entry 4c in Table 1), which is set to 100 on the black scale
bar on the right.
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end DNA residues were successively introduced into the target
strand, and trends already observed were indeed recapitulated.
For example, an exchange of rC38 against dC38 improved meth-
ylation (5i vs. 5e), or substitution of the 3’-side of the anticodon
stem against DNA entailed moderate losses in methylation (5c,
5f-5h, 5j) as was previously the case with covalent chimeras (4e,
4f, and 4g).
An extension of the DNA fragment on its 5’-end was toler-
ated, albeit with some loss of activity (compare 5c vs. 5f). In
comparison to the covalent chimeras, the newly implemented
exchange of the Asp anticodon sequence against an oligo-C
stretch was also tolerated by the enzyme (5 a,c,f,g,h,j). Subse-
quent extension of the acceptor stem helix led to moderate
improvement (5j vs. 5h), while the artiﬁcial introduction of an
extra helix in the anticodon domain led to a drop in methyla-
tion (5f vs. 5g) pointing to a dangling DNA single strand as the
better substrate. Indeed, a construct featuring a 5’-tRNA-half
hybridized to an RNA-DNA chimera with an oligo-C segment
was a good substrate (5a) and its DNA content could be
extended to the 3’ (5c) and the 5’ (5f) and still retained appreci-
able activity. An extension of the 5’-tRNA-half, designed to
form an additional helix, lowered activity (compare 5f vs. 5g),
pointing to a dangling DNA single strand as the better
substrate.
The next step was aimed at replacing the covalent RNA-
DNA chimera with 2 separate oligonucleotides, one DNA and
one RNA. The underlying rationale was that this would lead to
a ternary system of 2 RNA strands, which would be assembled
into a methylation competent complex upon hybridization
with the substrate DNA strand, effectively acting as artiﬁcial
guide RNAs in vitro. In case of the construct (5h), the hitherto
covalent link between the DNA and the RNA part was simply
omitted by using 2 separate oligomers, in essence replacing that
covalent link with a nick between positions 51 and 52. This par-
ticular construct (Fig. 6A) was chosen for 2 reasons, namely (i)
to have a maximum length of the DNA for hybridization onto/
into the tRNA scaffold, and (ii) because of the stretch of 4 con-
secutive G residues at positions 51-54 in the T-stem, which was
liable to induce potential misfolding by hybridization to C resi-
dues 26-29 if the nick was placed elsewhere. The corresponding
3 oligonucleotides needed to assemble the ternary tRNA struc-
tural mimic were submitted to a hybridization protocol, but a
subsequent test for tritium incorporation showed methylation
activity that was only »2 fold above the background signal. We
therefore changed the assay conditions to include higher
enzyme and SAM concentrations, and sampled at 15 and 120
minutes of incubation. Under these enhanced conditions how-
ever, a clear signal was measured, exceeding background by a
Figure 5. Relative methylation efﬁciency of 2-component hybrid-chimeric tRNAsAsp compared to the all-ribo tRNAAsp (entry 4c/5b in Table 1) which is set to 100 on the
black scale bar in the middle. Deviations from the native tRNAAsp sequence are presented in capital letters, DNA is highlighted in red.
RNA BIOLOGY 1245
factor of 2.8 after 15 minutes, and by a factor of 9.3 after 120
minutes in 3 replicates (Fig. 6B). Omission of the RNA frag-
ments resulted in signal intensity of background level (not
shown), conﬁrming that the methylation depended on the pres-
ence of the 2 “guide” RNAs.
To verify, that the methyl group of 3H-SAM was indeed
incorporated into the DNA strand our customary LC-MS assay
turned out to be inadequate, since the synthetic oligomers used
to assemble the various substrates were discovered to already
contain substantial amounts of non-radioactive m5C in both
RNA and DNA,30 which increased the background to a level
(compare Fig. 2) that precluded adequate quantiﬁcation. Of
note, the relative content of tritium in 3H-SAM is so low, that
detection of 3H-by LC-MS would require quantities incompati-
ble with biochemical handling and radiation safety. Instead, we
resorted to thin-layer chromatography (TLC) for detection of
tritium-containing dm5C. The reaction mixture was precipi-
tated, digested to mononucleosides, and separated by TLC in 2
dimensions after addition of authentic standards.34 The corre-
sponding spots were visualized on the TLC by UV light,
scratched from the plate, and the tritium quantiﬁed by scintilla-
tion counting. As shown in Fig. 7, recovered radioactivity
resided in the dm5C spot, showing that no formation of rm5C
was catalyzed in the RNA part of the substrate complex.
Discussion
As an opening remark, 3 classes of new Dnmt2 substrates have
been identiﬁed purely in vitro, and we are well aware that evi-
dence for their biological signiﬁcance is scarce in the absence of
in vivo data. However, one of the new substrate classes has a
known correspondent in tRNA biology, namely the all-RNA
hybrid composed of 2 RNA strands in Fig. 5j. Such tRNAs with
a nicked anticodon may result from incorrect tRNA splicing,
the action of ribotoxins or other endonuclease enzymes like
angiogenin, and the latter actually cleaves the Dnmt2 substrate
tRNAAsp.5 Our results imply, that tRNAs may still be methyl-
ated after cleavage, but also that the 5’-tRNA half can, in princi-
ple act as a the equivalent of a guide RNA in trans, directing the
methylation of Dnmt2 onto a single stranded short RNA such
as a tRF. Given that tRFs were found associated to RISC,36
modiﬁcations can be expected to affect RNAi, and might con-
stitute a pathway through which Dnmt2 inﬂuences RNAi.
Two other classes of newly deﬁned Dnmt2 substrates are of
interest in our quest to understand the origin and mechanism
of Dnmt2 catalytic action. The deﬁnition of a number of cova-
lent RNA-DNA chimeras with variegated substrate properties
illustrates, that Dnmt2 still bears strong traits of a DNA meth-
yltransferase. These ﬁndings are strongly supporting the result
Figure 6. Methylation of an RNA-guided DNA oligonucleotide by Dnmt2. (A) Structure of the hybridized construct. DNA shown in red. (B) Average values and standard
deviations of 3 tritium incorporation assays are shown.
Figure 7. (A) Two-dimensional thin-layer chromatography of nucleosides on a 10 cm x 10 cm cellulose TLC plate. The starting point is marked by an X. (B) Methylation of
an RNA-guided DNA oligonucleotide by Dnmt2. The oligonucleotides were hydrolyzed to nucleosides after the tritium incorporation assay, separated by 2D thin-layer
chromatography and analyzed with the Cherenkov counter. Tritium could only be detected in m5dC. Average values and standard deviations of 3 experiments are shown.
Control corresponds to background signal of the TLC plate. Note that an identical Fig. S4 with enhanced contrast can be found in the supplement.
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of multiple sequence alignments indicating that Dnmt2 has
evolved from a DNA methyltransferase precursor and the
DNA methylation activity might be considered an evolutionary
“relict” in terms of biochemical catalysis.26
Although our unexpected results cannot prove that any
DNA methylation by Dnmt2 does indeed occur in vivo, the fact
that constructs featuring small DNA stretches near the target
site (substrates 3a, 3b) actually improve methylation over the
bona ﬁde natural substrate tRNAAsp, is indeed very suggestive.
Based on our data one may speculate that different full or par-
tially single stranded all-DNA structures which present a target
deoxycytidine in a loop region, might function as Dnmt2
substrates.
Should Dnmt2 indeed never methylate DNA in vivo, then
our ﬁnding might be construed to signify that DNA at the tar-
get site of a methyltransferase is more easily amenable to cataly-
sis than RNA in general, e.g., because it facilitates base
ﬂipping.37 However, this is not the case for the TRM4 enzyme,
which does not accept a deoxyribonucleotide at its target posi-
tion C49 at all (Fig S1), thus supporting once more that the
DNA methylation activity of Dnmt2 is likely related to its evo-
lutionary ancestry among DNA methyltransferases.26
The substrates 3a-4i all contain DNA covalently linked to
RNA, and these chimeras are derived from a tRNA scaffold
whose structure depends, among other features, on the pres-
ence of A-form helices and a number of hydrogen bridges
mediated by 2’-OH groups.32 Both these features are gradually
diminished upon increasing the DNA content and the resulting
chimeras can reasonably be expected to gradually lose their
structural resemblance to a proper tRNA, a view which receives
support from the concomitantly fading methylation activity.
Our construction of an artiﬁcial guide RNA system that can
efﬁciently direct methylation activity onto a non-tRNA oligori-
bonucleotide, and, less efﬁciently, onto a single stranded DNA
strand, brings new concepts to the currently very lively ﬁeld of
nucleic acid modiﬁcation. While guide RNAs are well estab-
lished parts of several RNP complexes, e.g. effecting pseudouri-
dinylation,38,39 2’O-methylation,40,41 or U-insertion,42,43 the
fact that tRNA derived fragments may potentially turn any
given modiﬁcation enzyme into an RNA-guided modiﬁcation
RNP complex, can reasonably be expected to give impulse to
the ﬁeld. Of interest might be our attempts to simplify the tri-
partite DNA methylation system to a dual one by fusing the 2
guide RNA fragments. By applying again the splint ligation
approach we obtain »60% ligation yield, independently of
where within the tRNA structure the junction is situated.44
However, a series of resulting constructs featuring the former
CCA-3’-end now forming a loop between the former 5’ and 3’-
ends (Fig. 5 inset) were, surprisingly, completely inactive for
reasons yet to be evaluated, but likely linked to particular struc-
tural features of this loop (data not shown). This structural
impact is likely to somehow affect the local structure at the
remote modiﬁcation site, because the known data on the
enzyme suggest that its interaction with the substrate tRNA is
restricted to the anticodon stem loop structure.4,45
As a concluding remark, we are aware that the low efﬁciency
of our artiﬁcial DNA methylation system certainly quenches
hope that this very construct might exhibit any activity in vivo.
However, the principle possibility that Dnmt2 might do so in a
more appropriate structural context should certainly be consid-
ered. Since such context would be expected to contain both
RNA and DNA, possibly covalently linked, a future search
might be directed toward replication forks, transcription sites,
DNA repair events, or retroviral replication. However, even
viral, bacterial and eukaryotic RNA contain a certain amount
of DNA.46
Material and methods
Splinted ligation of hybrid tRNAs
Splinted ligation was performed as described previously, by
annealing 2 synthetic fragments (IBA G€ottingen, Germany, see
Table 2) of RNA or DNA:RNA hybrids, corresponding in
sequence to tRNAAsp from human (or mouse, as the sequences
are identical) onto a 52 nt long complementary oligodeoxynu-
cleotide.47 Appropriate fragments (4 nmol) were 5’-phosphory-
lated by incubating in KL buffer supplemented with 5 mM
ATP, 5 mM DTT and 0.75 u/ml T4 polynucleotide kinase
(PNK, Fermentas, Germany) in a ﬁnal volume of 150 ml in the
thermomixer at 37C for 1 h. To the phosphorylation reaction
mixture an equimolar amount of the 5’-fragment and the DNA
splint were added, as well as KL buffer, ATP (5 mM) and DTT
(5 mM) leading to a ﬁnal volume of 500 ml and a 8 mM concen-
tration of each fragment. The RNA fragments were hybridized
to the DNA splint by heating to 75C in the thermomixer for
4 min and letting the reaction mixture cool down to room tem-
perature for 15 min. Then T4 DNA ligase (1.5 u/ml; Fermentas)
and T4 RNA ligase 2 (22 ng/ml) were added and the ligation
was performed in the thermomixer at 16C over night. Tem-
plate DNA in constructs tRNAAspdC38 and all-ribo tRNAAsp
was removed by addition of 1.5 u/mL DNase I (Fermentas), fol-
lowed by 1 h of incubation at 37C. The DNase digestion was
omitted for hybrids containing DNA stretches of 3 nucleotides
in length or more. All tRNA and tRNA hybrids were puriﬁed
from ligation mixtures by denaturing PAGE, excised and eluted
from the gel, and precipitated with ethanol. Concentrations
were calculated from absorption at 254 nm, as determined on a
Nanodrop ND-1000 spectrometer.
Protein preparation
Cloning, expression and puriﬁcation by IMAC of the human
DNMT2-His6 fusion protein was performed as described
before.9,28 Expression was done in E. coli (DE3) Rosetta2 pLysS
cells. The protein expression was induced at OD(600 nm) D 0.6
with 1 mM IPTG and the cells were harvested 3 h after
induction.
Tritium incorporation assay of in vitro methylation
In vitro methylation was done essentially as described.27 The in
vitro methylation assay measures the transfer of a tritiated
methyl group from its donor [3H]-S-adenosyL-methionine (3H-
SAM , 1 mCi/mL, 80 Ci/ mmol, from Hartmann Analytics,
Braunschweig, Germany) onto the target tRNA, which is cata-
lyzed by m5C-methyltransferases. The tRNA is precipitated on
small ﬁlters and the radioactive signal counted in a scintillation
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counter. The standard reaction volume was 40 ml. Unless stated
otherwise, 120 pmol tRNA were diluted in water and heated to
65C for 2 min. tRNA-MT-assay buffer and DTT were added
immediately to ﬁnal concentrations of 100 mM Tris-HCl pH
8.0; 100 mM NH4OAc; 0.1 mM EDTA, 10 mM MgCl2 and
10 mM DTT. 3H-SAM-Stock solution (10x; containing cold and
3H-SAM) was added to a ﬁnal concentration of 0.9 mM SAM
and 1 mCi per sample. The enzyme was added to ﬁnal concen-
trations of 1 mM and mixed well by pipetting. At various time
points 8 mL aliquots were spotted onto small Whatman ﬁlters
and precipitated in 5 % ice-cold TCA, followed by 2 washes at
room temperature for 20 min and 10 min, respectively in 5 %
TCA. Then the ﬁlters were swirled in EtOH. After drying, the
Whatman ﬁlters were transferred into scintillation vials and 3 ml
Table 2. Oligonucleotides used in this study. Ribonucleotides are indicated by plain letters, deoxyribonucleotides are indicated as dC, dT, dA, dG, or dm5C.
Construct name 5‘ fragment 3‘ fragment
all-ribo tRNAAsp MH 565 UCCUCGUUAGUAUAGUG
GUGAGUAUCCCCGCCU
MH 566 GUCACGCGGGAGACCGGGGUU
CGAUUCCCCGACGGGGAGCCA
tRNAAspdC38 MH 565 UCCUCGUUAGUAUAGUGG
UGAGUAUCCCCGCCU
MH 571 GUCAdCGCGGGAGACCGGGGU
UCGAUUCCCCGACGGGGAGCCA
tRNAAspd37-39 MH 565 UCCUCGUUAGUAUAGUGGU
GAGUAUCCCCGCCU
MH 584 GUCdAdCdGCGGGAGACCGGGGU
UCGAUUCCCCGACGGGGAGCCA
tRNAAspd36-40 MH 565 UCCUCGUUAGUAUAGUGGU
GAGUAUCCCCGCCU
MH 585 GUdCdAdCdGdCGGGAGACCGGG
GUUCGAUUCCCCGACGGGGAGCCA
tRNAAspd34-43 MH 565 UCCUCGUUAGUAUAGUGG
UGAGUAUCCCCGCCU
MH 587 dGdTdCdAdCdGdCdGdGdGAGACC
GGGGUUCGAUUCCCCGACGGGGAGCCA
tRNAAspd34-46 MH 565 UCCUCGUUAGUAUAGUGGU
GAGUAUCCCCGCCU
MH 623 dGdTdCdAdCdGdCdGdGd
GdAdGdACCGGGGUUCGAU
UCCCCGACGGGGAGCCA
tRNAAspd34-51 MH 565 UCCUCGUUAGUAUAGUG
GUGAGUAUCCCCGCCU
MH 642 dGdTdCdAdCdGdCdGdGdGd
AdGdAdCdCdGdGGGUUCGAUUC
CCCGACGGGGAGCCA
tRNAAspd27-43 MH 586 UCCUCGUUAGUAUAGUGGUGA
GUAUCdCdCdCdGdCdCdT
MH 587 dGdTdCdAdCdGdCdGdGdGAGACC
GGGGUUCGAUUCCCCGACG
GGGAGCCA
tRNAAspd27-33 MH 586 UCCUCGUUAGUAUAGUGGUGA
GUAUCdCdCdCdGdCdCdT
MH 566 GUCACGCGGGAGACCGGGGUU
CGAUUCCCCGACGGGGAGCCA
tRNAAspd48-49 MH 565 UCCUCGUUAGUAUAGUGG
UGAGUAUCCCCGCCU
MH 621 GUCACGCGGGAGAdCdCGGGGUUC
GAUUCCCCGACGGGGAGCCA
tRNAAspdm5C38 MH 565 UCCUCGUUAGUAUAGUGGU
GAGUAUCCCCGCCU
MH 569 GUCAdm5CGCGGGAGACCGGGGUUC
GAUUCCCCGACGGGGAGCCA
Splint MH 570 dGdGdAdAdTdCdGdAdAdCdCd
CdCdGdGdTdCdTdCdCdCdGd
CdGdTdGdAdCdAdGdGdCdG dGd
GdGdAdTdAdCdTdCdAd
CdCdAdCdTdAdTdAdC
nicked tRNAAsp
dCdC38
MH 565 UCCUCGUUAGUAUAGUGG
UGAGUAUCCCCGCCU
MH 619 dCdCdCdCdCGCGGGA
GACCGGGGUUCGAUUCCCCG
ACGGGGAGCCA
nicked
tRNAAspdCdC38-
43
MH 565 UCCUCGUUAGUAUAGUGG
UGAGUAUCCCCGCCU
MH 638 dCdCdCdCdCdGdCdGdGd
GAGACCGGGGUUCGAUUCCC
CGACGGGGAGCCA
nicked tRNAAspdX-43 MH 565 UCCUCGUUAGUAUAGUGG
UGAGUAUCCCCGCCU
MH 643 dGdAdTdAdTdCdCdCdCdCd
GdCdGdGdGAGACCGGGGU
UCGAUUCCCCGACGGGGAGCCA
nicked tRNAAspdX-
43-3’HX
MH 646 UCCUCGUUAGUAUAGUGG
UGAGUAUCCCCGCCUAUAUC
MH 643 dGdAdTdAdTdCdCdCdCdCdGd
CdGdGdGAGACCGGGGUUCG
AUUCCCCGACGGGGAGCCA
nicked tRNAAspdC38 MH 565 UCCUCGUUAGUAUAGUG
GUGAGUAUCCCCGCCU
MH 571 GUCAdCGCGGGAGACCGGGGU
UCGAUUCCCCGACGGGGAGCCA
nicked tRNAAsp d27-
33
MH 586 UCCUCGUUAGUAUAGUGGU
GAGUAUCdCdCdCdGdCdCdT
MH 566 GUCACGCGGGAGACCGGGGU
UCGAUUCCCCGACGGGGAGCCA
nicked tRNAAspdX-53 MH 565 UCCUCGUUAGUAUAGUG
GUGAGUAUCCCCGCCU
MH 647 dGdAdTdAdTdCdCdCdCd
CdGdCdGdGdGdAdGdAdCdCd
GdGGGUUCGAUUCCCCGACG
GGGAGCCA
nicked all-ribo
tRNAAsp
MH 565 UCCUCGUUAGUAUAGUG
GUGAGUAUCCCCGCCU
MH 566 GUCACGCGGGAGACCGGGGU
UCGAUUCCCCGACGGGGAGCCA
nicked tRNAAspdX-
53-5’HX
MH 648 UGGCUCCUCGUUAGUAUAG
UGGUGAGUAUCCCCGCCU
MH 647 dGdAdTdAdTdCdCdCdCdCd
GdCdGdGdGdAdGdAdCdCd
GdGGGUUCGAUUCCCCGACG
GGGAGCCA
RgD MH 648 UGGCUCCUCGUUAGUAUA
GUGGUGAGUAUCCCCGCCU
MH 649 GGUUCGAUUCCC
CGACGGGGAGCCA
MH 650 (middle) dGdAdTdAdTdCdCdCdCdCdGd
CdGdGdGdAdGdAdCdCdGdG
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of Ultima Gold MV liquid scintillation cocktail (PerkinElmer,
Waltham, USA) were added into each vial. The incorporated tri-
tium was measured by liquid scintillation counting with a Wallac
1409 liquid scintillation counter (PerkinElmer, Waltham, USA).
Measuring duration was 60 sec per sample. 1 mL of the 10x
SAM-stock solution was spotted in duplicate as a standard for
speciﬁc activity. Initial reaction rates were extracted from methyl-
ation kinetics (Fig. S2) by linear regression after background cor-
rection. From the initial rates, Km and Vmax values were
obtained by a non-linear 2 component least square ﬁt, and kcat
was calculated from Vmax.
HPLC -MS analysis
0.5 mg of either Dnmt2 treated or untreated tRNA was dis-
solved in 20 mM NH4OAc pH 5.3 and digested to nucleosides
as described before.48 Additionally the commercial oligomer
MH569 (Table 1) containing deoxy-5-methyl-cytidine was
digested and used as a reference sample for MS fragmentation
experiments. For ribo-5-methyl-cytidine a commercial nucleo-
side was used (Sigma-Aldrich, Missouri, US).
The digested RNA was analyzed on an Agilent 1260 series
equipped with a diode array detector (DAD) and Triple Quad-
rupol mass spectrometer Agilent 6460. A Synergy Fusion RP
column (4 mm particle size, 80 A

pore size, 250 mm length,
2 mm inner diameter) from Phenomenex (Aschaffenburg,
Germany) was used at 35 C. The solvents consisted of 5 mM
ammonium acetate buffer adjusted to pH 5.3 using acetic acid
(solvent A) and pure acetonitrile (solvent B). The elution
started with 100% solvent A followed by a linear gradient to
20% solvent B at 10 min. Initial conditions were regenerated by
rinsing with 100% solvent A for 7 minutes. The ﬂow rate was
0.5 mL/min.
The efﬂuent from the column was ﬁrst measured photomet-
rical at 254 nm by the DAD followed by the mass spectrometer
equipped with an electrospray ion source (Agilent Jet Stream).
ESI parameters were as follows: gas temperature 300C, Gas
ﬂow 5 L/min, Nebulizer pressure 35 psi, Sheath gas temperature
350C, Sheath gas ﬂow 12 L/min, capillary voltage 3500 V. The
MS was operated in positive ion mode monitoring multiple
fragmentation reactions (MRM mode) at previously optimized
conditions. The transitions and retention times used for identi-
ﬁcation of nucleosides can be found in Table 3.
Thin layer chromatography
For the RgD Experiments the concentration of nucleic acid and
enzyme was doubled and the ratio of hot to cold SAM was
increased (2.3 mCi per sample). The total reaction volume was
50 ml. At two time points after reaction start (15 and 120
minutes), aliquots were spotted on a whatman ﬁlter paper and
measured with the Cherenkov counter. The remaining portion
of the sample was subjected to a nucleic acid precipitation with
LiClO4 in acetone to purify the nucleic acids. The precipitation
with perchlorate and acetone was chosen over standard EtOH
precipitation, as it is more suited to precipitate small oligonu-
cleotides. The pellet was then resuspended in H2O and further
puriﬁed with a MicroSpin G50 size-exclusion column (GE
Healthcare, Solingen, Germany). The puriﬁed oligonucleotides
were enzymatically hydrolyzed to nucleosides with nuclease P1,
snake venom phosphodiesterase and shrimp alkaline phospha-
tase. After the addition of commercially available nucleosides
as standards (all Sigma-Aldrich, Missouri, US, except dm5C,
Berry & Associates, Dexter, USA), the samples were concen-
trated and spotted on a 10 cm £ 10 cm cellulose TLC plate
(Merck ref#1.05577.000, Darmstadt, Germany) and subjected
to 2-dimensional thin-layer chromatography. For the ﬁrst
dimension the solvent was isobutyric acid : concentrated
ammonia : H2O (50 : 1.1 : 28.9 [v : v : v]) and for the second
dimension isopropanol : concentrated HCl : H2O (68 : 18 : 14
[v : v : v]). After each run the TLC plate was dried for several
hours in a fume hood. The nucleoside spots were visualized
with a UV-lamp (256 nm), marked with a pencil, and the cellu-
lose corresponding to a spot was scraped off with a scalpel and
transferred to a reaction tube. The nucleosides were extracted
with water and subjected to liquid scintillation counting.
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